Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.

Earlier, Novo Nordisk A/S (NYSE:NVO) petitioned the FDA to ban compounding pharmacies from producing cheaper, unapproved ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

We reached out to Novo Nordisk, the company that manufactures ... including doctors, pharmacies, and other experts in the field, and just like Ann, we heard mixed things about why there could ...

Type 1 Diabetes Market is expected to reach USD 24.36 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031. BURLINGAME, CA, UNITED STATES, October 27, 2024 ...

Novo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

The article included a statement made by a Novo Nordisk global senior leader that the regulator said “promoted a prescription only medicine to the public in a way that was misleading.” The statement ...

The Danish drug company Novo Nordisk has been sanctioned by the UK pharmaceutical ... and “inappropriate sponsorship arrangements.” The Prescription Medicines Code of Practice Authority (PMCPA), the ...

Kubapharm.com was issued a warning letter by the FDA on March 30, 2022 for selling drugs without requiring a prescription and lacking DEA registration on the website. The screenshot taken October ...

Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity care. The company develops a long line of blockbuster glucagon-like ...